Tobacco Products
FDA’s Center for Tobacco Products (CTP) works to ensure a healthier life for every family.
Topic Paragraphs
Latest Updates from the Center for Tobacco Products
FDA’s Progress on Tobacco Product Regulation in 2022
CTP Director Brian King looks back at 2022 focusing on topics including non-tobacco nicotine, product standards, health equity, and product review.
FDA Denies Marketing of Two Vuse Menthol E-Cigarette Products
FDA Determined that Vuse’s Vibe and Ciro Menthol E-Cigarette Product Do Not Meet the Public Health Standard.
FDA Releases New Youth Cigarette Prevention Ads
“The Real Cost” Youth Cigarette Prevention Campaign will focus on the negative mental health effects of cigarette smoking and withdrawal in a new ad.
Tobacco Product Marketing Orders
To legally market a new tobacco product, manufacturers must submit an application to FDA and receive a marketing authorization from FDA. When a new tobacco product is granted a marketing order, information is posted online for public awareness. FDA notes that in accordance with a court order, deemed new tobacco products that were on the market as of August 8, 2016 were required to submit an application to FDA by September 9, 2020 or risk enforcement.
Learn More About the Latest Marketing Decisions
Regulation and Enforcement of Non-Tobacco Nicotine (NTN) Products
A new federal law gives FDA the authority to regulate tobacco products containing nicotine from any source. This law took effect April 14, 2022, and after July 13, 2022, any new non-tobacco nicotine (NTN) product that has not received premarket authorization from FDA cannot be legally marketed. FDA launched a webpage that includes up-to-date information about premarket review progress and compliance and enforcement actions.
Learn more
Contact CTP
1-877-287-1373 (9am - 4pm ET)
For General Inquiries: AskCTP@fda.hhs.gov
Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002